U.S. Countervailing Duty Findings on KG Dongbu Steel Upheld by CIT
What happened
On October 20, 2026, the U.S. Court of International Trade, in Slip Op. 26-130 in Court No. 22-00047, reversed its earlier conclusions in KG Dongbu I, KG Dongbu II and KG Dongbu III to conform to the Federal Circuit's opinion in KG Dongbu IV, 181 F.4th 1335 (Fed. Cir. 2026). The court upheld Commerce's reconsideration of the first three equity infusions, its determination of a countervailable benefit, and its finding that the benefit passed through on KG Consortium's acquisition, holding each supported by substantial evidence and not contrary to law. The reports do not state a rate, effective date or further deadline.
Generated by AI from the reports · updated 8 days ago
Report timeline
Follow the reports to see the story from each side.
- CIT · Slip OpinionsCIT reverses its earlier rulings and upholds Commerce's countervailable benefit findings in KG Dongbu Steel case
The U.S. Court of International Trade, in Slip Op. 26-130 in Court No. 22-00047, reversed its conclusions in KG Dongbu I, KG Dongbu II and KG Dongbu III to conform to the Federal Circuit's opinion in KG Dongbu IV, 181 F.4th 1335 (Fed. Cir. 2026), and held that Commerce's reconsideration of the first three equity infusions, its determination of a countervailable benefit and its finding that the benefit passed through on KG Consortium's acquisition were supported by substantial evidence and not contrary to law.